Drug and Medical Devices
Wagstaff & Cartmell has a national practice representing individuals injured by prescription drugs and by medical devices that have caused them harm. In 2008, Wagstaff & Cartmell was one of a small number of firms in the United States with a lead role in negotiating and securing an $894 million settlement from Pfizer, Inc., on behalf of thousands of individuals across the United States who had taken the anti-inflammatory medicines Bextra and Celebrex, manufactured by Pfizer. Tom Cartmell was a member of the national Plaintiff's Steering Committee in the Bextra/Celebrex Multi-District Litigation, and he was a part of the trial team that was set to take the first Bextra case to trial against Pfizer in May of 2008, which prompted the first round of settlements.
Our firm has pursued, or is pursuing, litigation or investigations involving the following drugs:
- Accutane
- Actonel
- Avandia
- Baycol
- Bextra
- Byetta
- Celebrex
- Chantix
- Depo-Provera
- Digitek
- Ephedra
- Fixodent
- Fleet
- Foradil
- Fosamax
- Gadolinium
- Heparin
- Levaquin
- Propulsid
- Reglan
- Remicade
- Rezulin
- Seroquel
- Trasylol
- Tylenol
- Vioxx
- Vytorin
- Yasmin
- Zicam
- Zyprexa
In addition to pharamaceutical cases, Wagstaff & Cartmell has been and remains active in several cases on behalf of plaintiffs who have been injured from complications from defective medical devices. For example, Jeffrey Kuntz is on the national Plaintiff's Steering Committee in the Bard® Composix® Kugel® Mesh Patch Multi-District Litigation.
Our firm has pursued, or is pursuing, litigation or investigations involving the following medical devices:
- Hernia Mesh Patches (Bard® Composix® Kugel®)
- Implanted defibrillators
- Shoulder Pain Pumps (multiple manufacturers)
- Transvaginal Mesh Patch